Interstitial Cystitis Market Size and Forecast 2024-2033| Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG,

Overview and Scope

Interstitial cystitis (IC) is a chronic condition that causes bladder pain and pressure that can be mild or severe and can be constant or come and go. It is characterized by pain, stress, or discomfort associated with the urinary bladder that lasts more than six months. The use of tricyclic antidepressants, antihistamines and bladder instillations can help relieve pain and reduce inflammation.

Sizing and Forecast

The interstitial cystitis market size has grown strongly in recent years. It will grow from $1.69 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to advancements in diagnosis, awareness and education, pharmaceutical developments, supportive therapies.

The interstitial cystitis market size is expected to see strong growth in the next few years. It will grow to $2.53 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to biomarker research, innovative medications, patient-centered care, global expansion. Major trends in the forecast period include dietary guidance, interdisciplinary care, research collaboration, alternative therapies.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/interstitial-cystitis-global-market-report

Segmentation & Regional Insights

The interstitial cystitis market covered in this report is segmented –

1) By Treatment: Medications; Bladder Instillation; Botulinum Toxin A; Nerve Stimulation; Surgery

2) By Patient Type: Pediatric Patients; Adult Patients

3) By Drug Type: Over-The-Counter (OTC) Drugs; Prescription Drugs

4) By End User: Hospitals And Clinics; Homecare

North America was the largest region in the interstitial cystitis market in 2023. The regions covered in interstitial cystitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13041&type=smp

Major Driver Impacting Market Growth

The rising prevalence of urinary tract infections is expected to propel the growth of the interstitial cystitis market. Urinary tract infections are bacterial infections that can occur anywhere in the urinary system and are caused by bacteria that enter the urethra. UTI can induce bacterial cystitis directly or indirectly and untreated UTI can lead to persistent bladder inflammation, the underlying cause of interstitial cystitis. Treatment for urinary tract infections caused by interstitial cystitis improves pain alleviation and quality of life in patients suffering from the disease. For instance, in 2021, according to the Centers for Disease Control and Prevention, a US-based national public health agency, in the US there were around 24,710 catheter-associated urinary tract infections reported in 2021. Further, according to an article published by The British Society for Antimicrobial Chemotherapy, a UK-based multi-professional organization, estimated that almost half of all women in the United Kingdom will get at least one urinary tract infection (UTI) at some point in their lives. Therefore, the rising prevalence of urinary tract infections drives the interstitial cystitis market.

Key Industry Players

Major players in the interstitial cystitis market are Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim international GmbH, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Perrigo Company PLC, Aurobindo Pharma Ltd., Purdue Pharma LP, Apotex Inc., Endo International PLC, Amneal Pharmaceuticals Inc., Alvogen Inc., Kyorin Pharmaceutical Co. Ltd., Seikagaku Corp, Genentech Inc., Strides Pharma Science Limited, AlgoTherapeutix SAS.

The interstitial cystitis market report table of contents includes:

1. Executive Summary

2. Interstitial Cystitis Market Characteristics

3. Interstitial Cystitis Market Trends And Strategies

4. Interstitial Cystitis Market – Macro Economic Scenario

5. Global Interstitial Cystitis Market Size and Growth

26. South America Interstitial Cystitis Market

27. Brazil Interstitial Cystitis Market

28. Middle East Interstitial Cystitis Market

29. Africa Interstitial Cystitis Market

30. Interstitial Cystitis Market Competitive Landscape And Company Profiles

Top Major Players: